Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/24/2015 06/25/2015 06/26/2015 06/29/2015 06/30/2015 Date
184.98(c) 185.9(c) 184.45(c) 177.76(c) 176.92 Last
3 454 491 2 486 025 2 315 549 2 370 197 342 270 Volume
-3.11% +0.50% -0.78% -3.63% -0.47% Change
More quotes
Financials ($)
Sales 2015 2 627 M
EBIT 2015 1 155 M
Net income 2015 571 M
Finance 2015 2 246 M
Yield 2015 -
Sales 2016 3 390 M
EBIT 2016 1 597 M
Net income 2016 908 M
Finance 2016 3 044 M
Yield 2016 -
PER 2015 65,35
PER 2016 40,75
EV / Sales 2015 14,4x
EV / Sales 2016 10,9x
Capitalization 40 139 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
07/23Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
06/26 ALEXION PHARMACEUTICALS : Receives CHMP Positive Opinions for Strensiq™ (a..
06/26 ALEXION PHARMACEUTICALS : Finalizes Acquisition of Synageva
06/23 ALEXION PHARMACEUTICALS : Entry into a Material Definitive Agreement, Terminatio..
06/22 ALEXION PHARMACEUTICALS : Accepts Shares of Synageva BioPharma Corp. Tendered In..
06/03 ALEXION PHARMACEUTICALS : and Synageva Report Early Termination of HSR Waiting P..
06/02 ALEXION PHARMACEUTICALS : to Present at Investor Conferences
05/29 ALEXION PHARMACEUTICALS : and Synageva Announce Early Termination of Hart-Scott-..
05/24 ALEXION PHARMACEUTICALS : Behind this door to a hospital pharmacy is a drug that..
More news
Sector news : Biopharmaceuticals
09:45a JUNO THERAPEUTICS : Celgene, Juno map out cancer treatment collaboration
08:48a NOVARTIS : deepens its industry leading pipeline with acquisition of Spinifex Ph..
08:31a ZOETIS : to Host Webcast and Conference Call on Second Quarter 2015 Financial Re..
More sector news : Biopharmaceuticals
News from SeekingAlpha
06/26 Europe's CHMP adopts positive opinion supporting approval for two Alexion enz..
06/22 INSIDERINSIGHTS.COM DAILY ROUND UP 6 : Banc, ntip, lub, alxn
06/19 Is Biotech Finally In A Bubble?
06/18 Amgen - A Reasonably Priced Biotech
06/12 Alnylam's CC5 Data More Like A Long Foul Than A Home Run Or Strikeout


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions